US FDA’s Cavazzoni To Manufacturers: Pay Attention To Data Received From CROs

 
• By Anju Ghangurde
  
The FDA flags concerns about data integrity issues at CROs • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation